Bristol-Myers Is For Sale
Bristol-Myers Squibb, the $20 billion (sales) pharmaceutical giant, has put itself up for sale, according to a news report from Reuters. Itself a product of the 1989 merger of Bristol-Myers and Squibb Corporation, the company is said to be examining a number of options, including a possible combination with GlaxoSmithKline.
Click here to read the Reuters report.
Want to use this article? Click here for options!
© 2008 Penton Media Inc.
advertisement
The Meeting Planning Blog
Face2Face Latest Posts
advertisement
Webinars
Is This Meeting Really Necessary? Owning Visibility and Control of Your Company's Meetings Spend
Tuesday, June 24, 2008 at 1:00pm ET
Join Corporate Meetings & Incentives’ newest columnist, Betsy Bondurant, formerly of Amgen and now a meetings management consultant, for a free eye-opening web seminar on strategic meetings management. Discover how you can better control your corporate-wide meetings spend without losing the strategic value of your meetings and events. Webinar Registration
advertisement
Podcasts
VolunTourism and Meetings
Corporate Meetings & Incentives Editor Barbara Scofidio speaks about companies that give back to the community.
